Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 5Parasomnias 3Neoplasms 3Tuberous Sclerosis 2Smith-Magenis Syndrome 2Lung Neoplasms 2Autism Spectrum Disorder 2Angelman Syndrome 2Weight Loss 1Squamous Cell Carcinoma of Head and Neck 1Sleep Wake Disorders 1Sleep Disorders, Circadian Rhythm 1Relapsed Malignant Solid Tumor 1Radiodermatitis 1Radiation Injuries 1Polycystic Ovary Syndrome 1Pain 1Neoplasm Metastasis 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Fatigue 1Depression 1Delirium 1Carcinoma, Non-Small-Cell Lung 1Cachexia 1Brain Neoplasms 1Barrett Esophagus 1Anorexia 1

Interventions

Fentanyl 19Analgesia 15Acupuncture Therapy 13Oxycodone 12Zoledronic Acid 11Surveys and Questionnaires 10nabiximols 9Therapeutics 9Morphine 9Acetaminophen 9Psychiatric Rehabilitation 8Ketamine 8Hydromorphone 7Lidocaine 6Ibandronic Acid 6Radiotherapy 5Early Intervention, Educational 5Bupivacaine 5Analgesics, Opioid 5Yoga 4Transcutaneous Electric Nerve Stimulation 4Therapeutic Touch 4Ropivacaine 4Music Therapy 4Methadone 4Massage 4Aromatherapy 4alvimopan 3Tapentadol 3Saline Solution 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Pain × Melatonin × Clear all
NCT03205033 2017-07-02

Melatonin as a Circadian Clock Regulator, Neuromodulator and Myelo-protector in Adjuvant Breast Cancer Chemotherapy

Hospital de Clinicas de Porto Alegre

Phase 2 Completed
36 enrolled
Breast

Breast Neoplasms, Depression, Pain, Sleep Disorders, Circadian Rhythm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡